CELYAD ONCOLOGY SA Patent Applications Pending
3 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-12-20: Application 18989015; Invention POOLING SIGNALING AND COSTIMULATORY DOMAINS IN B7H6 CHIMERIC ANTIGEN RECEPTOR; Applicant CELYAD S.A.; Status Docketed New Case - Ready for Examination.
- 2024-12-19: Application 18986849; Invention COMPOSITIONS AND METHODS FOR IMPROVING PERSISTENCE OF CELLS FOR ADOPTIVE TRANSFER; Applicant CELYAD S.A.; Status Docketed New Case - Ready for Examination.
- 2023-03-24: Application 18125762; Invention REDUCING FRATRICIDE OF IMMUNE CELLS EXPRESSING NKG2D-BASED RECEPTORS; Applicant CELYAD S.A.; Status Final Rejection Mailed.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2024-12-20 | 18989015 | POOLING SIGNALING AND COSTIMULATORY DOMAINS IN B7H6 CHIMERIC ANTIGEN RECEPTOR | CELYAD S.A. | Docketed New Case - Ready for Examination | US20250197470A1 | David GILHAM Jennifer BOLSÉE Lorraine SPRINGUEL | Belgium Belgium Belgium | CENTRAL, DOCKET |
| 2024-12-19 | 18986849 | COMPOSITIONS AND METHODS FOR IMPROVING PERSISTENCE OF CELLS FOR ADOPTIVE TRANSFER | CELYAD S.A. | Docketed New Case - Ready for Examination | US20250197805A1 | David GILHAM Simon Bornschein Susanna Raitano | Belgium Belgium Belgium | CENTRAL, DOCKET |
| 2023-03-24 | 18125762 | REDUCING FRATRICIDE OF IMMUNE CELLS EXPRESSING NKG2D-BASED RECEPTORS | CELYAD S.A. | Final Rejection Mailed | US20230348855A1 | David GILHAM Eytan BREMAN Benjamin DEMOULIN Simon BORNSCHEIN Susanna RAITANO | Belgium Belgium Belgium Belgium Belgium | MOSELEY II, NELSON B |